Medicus Sciences Acquisition (MSAC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MSAC Annual Balance Sheets →
Examining balance sheet movements between Medicus Sciences Acquisition and Sep 30 2021 reveals how Sep 30 2022 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2022)
(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Assets
Cash & cash equivalent0.98
Cash & Short-term Investments0.00
Due from Related Parties, Current RE0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.07
Total Current Assets1.05
Other Assets, Noncurrent92.00
Derivative Assets Forward Purchase Agreement0.00
Total Assets93.43
Liabilities
Accrued Liabilities, Current AC0.06
Other Liabilities, Current0.00
Total Current Liabilities0.06
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE1.36
Other liabilities, Noncurrent2.45
Accrued Offering Costs And Accrued Liabilities Current0.00
Deferred Underwriting Commissions Noncurrent2.30
Total Liabilities3.87
Stockholders' Equity
Common Stock Value0.00
Retained Earnings / Accumulated Deficit-2.82
Other Equity-92.39
Common Stockholder's Equity-95.21
Non-controlling interests & other92.39
Total Stockholder's Equity-2.82
Liabilities & Stockholder's Equity93.43
4 historic quarters locked

Sign in to unlock the full Medicus Sciences Acquisition balance sheet history.

About Medicus Sciences Acquisition Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-22-118537

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.